Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome
- PMID:20368182
- DOI: 10.1126/scitranslmed.3000258
Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome
Abstract
Down syndrome (trisomy 21) is the most common cause of mental retardation in children and leads to marked deficits in contextual learning and memory. In rodents, these tasks require the hippocampus and are mediated by several inputs, particularly those originating in the locus coeruleus. These afferents mainly use norepinephrine as a transmitter. To explore the basis for contextual learning defects in Down syndrome, we examined the Ts65Dn mouse model. These mice, which have three copies of a fragment of mouse chromosome 16, exhibited significant deficits in contextual learning together with dysfunction and degeneration of locus coeruleus neurons. However, the postsynaptic targets of innervation remained responsive to noradrenergic receptor agonists. Indeed, despite advanced locus coeruleus degeneration, we were able to reverse contextual learning failure by using a prodrug for norepinephrine called l-threo-3,4-dihydroxyphenylserine, or xamoterol, a beta(1)-adrenergic receptor partial agonist. Moreover, an increased gene dosage of App, in the context of Down syndrome, was necessary for locus coeruleus degeneration. Our findings raise the possibility that restoring norepinephrine-mediated neurotransmission could reverse cognitive dysfunction in Down syndrome.
Comment in
- Cognitive enhancement therapy for a model of Down syndrome.Wiseman FK.Wiseman FK.Sci Transl Med. 2009 Nov 18;1(7):7ps9. doi: 10.1126/scitranslmed.3000449.Sci Transl Med. 2009.PMID:20368181
Similar articles
- Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.Faizi M, Bader PL, Tun C, Encarnacion A, Kleschevnikov A, Belichenko P, Saw N, Priestley M, Tsien RW, Mobley WC, Shamloo M.Faizi M, et al.Neurobiol Dis. 2011 Aug;43(2):397-413. doi: 10.1016/j.nbd.2011.04.011. Epub 2011 Apr 17.Neurobiol Dis. 2011.PMID:21527343Free PMC article.
- Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome.Dang V, Medina B, Das D, Moghadam S, Martin KJ, Lin B, Naik P, Patel D, Nosheny R, Wesson Ashford J, Salehi A.Dang V, et al.Biol Psychiatry. 2014 Feb 1;75(3):179-88. doi: 10.1016/j.biopsych.2013.05.024. Epub 2013 Jul 1.Biol Psychiatry. 2014.PMID:23827853
- Cognitive enhancement therapy for a model of Down syndrome.Wiseman FK.Wiseman FK.Sci Transl Med. 2009 Nov 18;1(7):7ps9. doi: 10.1126/scitranslmed.3000449.Sci Transl Med. 2009.PMID:20368181
- Neurobiological elements of cognitive dysfunction in down syndrome: exploring the role of APP.Millan Sanchez M, Heyn SN, Das D, Moghadam S, Martin KJ, Salehi A.Millan Sanchez M, et al.Biol Psychiatry. 2012 Mar 1;71(5):403-9. doi: 10.1016/j.biopsych.2011.08.016. Epub 2011 Sep 25.Biol Psychiatry. 2012.PMID:21945306Review.
- Using mouse models to explore genotype-phenotype relationship in Down syndrome.Salehi A, Faizi M, Belichenko PV, Mobley WC.Salehi A, et al.Ment Retard Dev Disabil Res Rev. 2007;13(3):207-14. doi: 10.1002/mrdd.20164.Ment Retard Dev Disabil Res Rev. 2007.PMID:17910089Review.
Cited by
- Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome.Stagni F, Magistretti J, Guidi S, Ciani E, Mangano C, Calzà L, Bartesaghi R.Stagni F, et al.PLoS One. 2013 Apr 19;8(4):e61689. doi: 10.1371/journal.pone.0061689. Print 2013.PLoS One. 2013.PMID:23620781Free PMC article.
- Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues.Belichenko PV, Kleschevnikov AM, Becker A, Wagner GE, Lysenko LV, Yu YE, Mobley WC.Belichenko PV, et al.PLoS One. 2015 Jul 31;10(7):e0134861. doi: 10.1371/journal.pone.0134861. eCollection 2015.PLoS One. 2015.PMID:26230397Free PMC article.
- Trisomy 21 and early brain development.Haydar TF, Reeves RH.Haydar TF, et al.Trends Neurosci. 2012 Feb;35(2):81-91. doi: 10.1016/j.tins.2011.11.001. Epub 2011 Dec 9.Trends Neurosci. 2012.PMID:22169531Free PMC article.Review.
- Altered synaptic marker abundance in the hippocampal stratum oriens of Ts65Dn mice is associated with exuberant expression of versican.Howell MD, Gottschall PE.Howell MD, et al.ASN Neuro. 2012 Feb 8;4(1):e00073. doi: 10.1042/AN20110037.ASN Neuro. 2012.PMID:22225533Free PMC article.
- Lowering beta-amyloid levels rescues learning and memory in a Down syndrome mouse model.Netzer WJ, Powell C, Nong Y, Blundell J, Wong L, Duff K, Flajolet M, Greengard P.Netzer WJ, et al.PLoS One. 2010 Jun 3;5(6):e10943. doi: 10.1371/journal.pone.0010943.PLoS One. 2010.PMID:20532168Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases